⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GTBP News
GT Biopharma Inc. Common Stock
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
globenewswire.com
GTBP
The $13 Million Company Teaching the Immune System to Hunt Cancer
prnewswire.com
NKTX
GTBP
IBRX
FATE
ARTV
Form 8-K
sec.gov
GTBP
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes
prnewswire.com
NKTX
GTBP
IBRX
FATE
INMB
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
prnewswire.com
IPHA
GTBP
GSK
SMMT
IDYA
GT Biopharma Reports First Quarter 2026 Financial Results
globenewswire.com
GTBP
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
globenewswire.com
GTBP
VIR
ONCY
SNSE
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
globenewswire.com
GTBP
SMMT
IDYA
RADX
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
prnewswire.com
GTBP
ARTV
FATE
IBRX
CHRS
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
globenewswire.com
GTBP